Imidazolidine-2,4,5- and pirimidine-2,4,6-triones – new primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility.

A series of inhibitors of the soluble epoxide hydrolase (sEH) containing imidazolidine-2,4,5-trione or pirimidine-2,4,6-trione has been synthesized. Inhibition potency of the described compounds ranges from 8.4 μM to 0.4 nM. The tested compounds possess higher water solubility than their preceding u...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Bioorg Med Chem Lett
Main Authors: Burmistrov, Vladimir, Morisseau, Christophe, D’yachenko, Vladimir, Karlov, Dmitry, Butov, Gennady M., Hammock, Bruce D.
Formato: Artigo
Idioma:Inglês
Publicado: 2019
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6957307/
https://ncbi.nlm.nih.gov/pubmed/31870649
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmcl.2019.126908
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares